Show simple item record

Neoplasia de células dendríticas plasmocitoides blásticas con respuesta inicial a quimioterapia y recaída en sistema nervioso central.

dc.contributoren-US
dc.contributores-ES
dc.creatorContreras, Loreto; Facultad de Medicina, Universidad de Concepción
dc.creatorMercado, Loreto; Hospital Regional de Concepción "Dr. Guillermo Grant Benavente"
dc.creatorDelgado, Carolina; Hospital Regional de Concepción "Dr. Guillermo Grant Benavente"
dc.creatorCabezas, Claudia; Hospital Regional de Concepción "Dr. Guillermo Grant Benavente"
dc.creatorStarke, Laksmi; Hospital Regional de Concepción "Dr. Guillermo Grant Benavente"
dc.creatorRomero, Mónica; Hospital Regional de Concepción "Dr. Guillermo Grant Benavente"
dc.creatorIbieta, Fernando; Hospital Regional de Concepción "Dr. Guillermo Grant Benavente"
dc.creatorHenríquez, Mauricio; Hospital Regional de Concepción "Dr. Guillermo Grant Benavente"
dc.creatorChandía, Mauricio; Hospital Regional de Concepción "Dr. Guillermo Grant Benavente"
dc.date2016-11-28
dc.date.accessioned2019-11-11T18:27:40Z
dc.date.available2019-11-11T18:27:40Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/4795
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111250
dc.descriptionBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, clinically aggressive hematologic malignancy that most commonly manifests as cutaneous lesions with or without bone marrow involvement and leukemic dissemination. The demonstration of tumor cells with the characteristic immunophenotype with expression of CD56, generally CD4 and dendritic cell antigens (CD123, cyTCL-1, HLA-DR), in the absence of myeloid or lymphoid lineage markers is required for the diagnosis. Responses to chemotherapy are initially satisfactory, with frequent systemic and central nervous system relapses. We report a 24 years old male with BPDCN, initially diagnosed and treated as non-Hodgkin CD4+ T-cell lymphoma, with initial complete remission who evolved with early central nervous system relapse. A second attempt of chemotherapy failed and the patient died two months later.en-US
dc.descriptionBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, clinically aggressive hematologic malignancy that most commonly manifests as cutaneous lesions with or without bone marrow involvement and leukemic dissemination. The demonstration of tumor cells with the characteristic immunophenotype with expression of CD56, generally CD4 and dendritic cell antigens (CD123, cyTCL-1, HLA-DR), in the absence of myeloid or lymphoid lineage markers is required for the diagnosis. Responses to chemotherapy are initially satisfactory, with frequent systemic and central nervous system relapses. We report a 24 years old male with BPDCN, initially diagnosed and treated as non-Hodgkin CD4+ T-cell lymphoma, with initial complete remission who evolved with early central nervous system relapse. A second attempt of chemotherapy failed and the patient died two months later.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/4795/2753
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22118
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22121
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22122
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22123
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22124
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22125
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22126
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22127
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22128
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22129
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22177
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/22409
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4795/25734
dc.sourceRevista Médica de Chile; Vol. 145, núm. 1 (2017): ENERO 2017es-ES
dc.source0034-9887
dc.subjectCentral Nervous System; Cytometry, Flow; Dentritic Cells, Plasmocytoiden-US
dc.subjectCentral Nervous System; Cytometry, Flow; Dentritic Cells, Plasmocytoides-ES
dc.titleBLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM WITH COMPLETE CLINICAL REMISSION WITH CHEMOTHERAPY AND CENTRAL NERVOUS SYSTEM RELAPSE. REPORT OF ONE CASEen-US
dc.titleNeoplasia de células dendríticas plasmocitoides blásticas con respuesta inicial a quimioterapia y recaída en sistema nervioso central.es-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record